News about Tyrosinemia [TYPE 1]

Hey, you guys should now have a pretty good idea what Tyrosinemia Type I is all about right?

Here are some recent news regarding Tyrosinemia Type I to serve as some additional reading materials! :)

Reports Summarize Metabolism Study Results from Medical University

2012 AUG 6 (NewsRx) -- By a News Reporter-Staff News Editor at Pain & Central Nervous System Week -- A new study on Metabolism is now available. According to news reporting originating from Vienna, Austria, by NewsRx correspondents, research stated, "Newborn screening for tyrosinemia type I (Tyr-I) is mandatory to identify infants at risk before life-threatening symptoms occur. The analysis of tyrosine alone is limited, and might lead to false-negative results."... read more here

Research from University Children's Hospital Provide New Insights into Tyrosinemia

2012 SEP 26 (NewsRx) -- By a News Reporter-Staff News Editor at Biotech Week -- Current study results on Tyrosinemia have been published. According to news reporting originating in Dusseldorf, Germany, by NewsRx journalists, research stated, "NTBC (2-(2-nitro-4-trifluoromethylbenzoyl)-1,3cyclohexanedione) is the mainstay of treatment in tyrosinemia type 1 (HT 1). The current recommendation is to divide the total daily dose of NTBC into two doses." ... read more here

Nitisinone treatment effectively prevents tyrosinemia in children

"A consortium of Quebec researchers coordinated by the Medical Genetics Service of the Sainte-Justine UHC has just published the findings of a 25-year study on the treatment of tyrosinemia, a life-threatening liver disease of genetic origin, which is screened at birth in the province of Quebec, where it is much more frequent than anywhere else in the world. "After five years of treatment, no trace of the disease can be detected in the liver of newborns who were treated with nitisinone starting from the first month of life," states Dr. Grant Mitchell of the Sainte-Justine UHC and the University of Montreal, who is the senior author of a study published in Molecular Genetics and Metabolism in September 2012. "... read more here